31 research outputs found
Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer
Get PDF
A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis
Full text link
